Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLB1 | P16278 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16980588 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL13170766 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL12745880 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL8324123 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL16079839 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL19129781 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL25495867 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL16883362 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL17680204 | 1.00 | GLB1 (0.34) | GLB1CA2CA1CA9ALDH1A1 | |
| SCHEMBL19799250 | 0.88 | GLB1 (0.33) | GLB1CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170360924-A1 | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS WITH ALTERED GLYCOSYL GROUPS | ACADEMIA SINICA (TW) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360924-A1 | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS WITH ALTERED GLYCOSYL GROUPS | UGCG, GALK1, B3GAT3 | GLB1 27/4885CA2 3196/4885CA1 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.